发明名称 Sunitinib and salts thereof and their polymorphs
摘要 Process for the preparation of sunitinib malate form I via sunitinib acetate and polymorphs of said intermediate.
申请公布号 US9067915(B2) 申请公布日期 2015.06.30
申请号 US201313944699 申请日期 2013.07.17
申请人 Teva Pharmaceutical Industries LTD. 发明人 Jegorov Alexandr;Gavenda Ales;Vraspir Pavel;Canavesi Augusto;Scarpitta Francesca
分类号 C07D209/12;C07D403/06 主分类号 C07D209/12
代理机构 Baker & Hostetler, LLP 代理人 Baker & Hostetler, LLP
主权项 1. A crystalline form of Sunitinib acetate characterized by data selected from the group consisting of: a PXRD pattern having peaks at about 6.1, 11.0, 15.8, 16.4 and 20.2±0.2 degrees 2-theta, a PXRD pattern as depicted in FIG. 17, a solid-state 13C NMR spectrum having signals at about 166.1, 133.0, 119.0, 114.5, 109.9 and 108.6±0.2 ppm, a solid-state 13C NMR spectrum having chemical shifts differences between the signal exhibiting the lowest chemical shift and another in the chemical shift range of 100 to 180 ppm of about 65.0, 31.9, 17.9, 13.4, 8.8 and 7.5±0.1 ppm, a solid-state 13C NMR spectrum depicted in FIG. 21; and combinations thereof.
地址 Petach-Tikva IL